Voices of society: the emergence of civil-society practices aiming to engage in the management of the COVID-19 pandemic in the Netherlands.

COVID-19 control strategies health policy public health qualitative study

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
08 2023
Historique:
received: 17 05 2023
accepted: 08 08 2023
medline: 24 8 2023
pubmed: 23 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

During the COVID-19 pandemic, public groups mobilised themselves in civil-society engagement practices (CSEPs) aiming to improve or suggest alternative epidemic management. This study explores the motivation to establish CSEPs and their perceived contributions to epidemic management, to gain insight whether integrating views of CSEPs could add value. A systematic online search was executed to identify CSEPs focused on COVID-19 management between January 2020 and January 2022 in the Netherlands. In order to create a comprehensible overview of the identified CSEPs, relevant characteristics were gathered and mapped, for example, local or national scope, subject of action and goals. A selection of CSEPs was interviewed between April and June 2022 to study their motivators to start the CSEPs and perceived contributions to management. The search resulted in the identification of 22 CSEPs, of which members of 14 CSEPs were interviewed. These members indicated several issues that motivated the start of their CSEP, namely; shortage of equipment, sense of solidarity, and a perceived lack of governmental action, lack of democratic values and lack in diversity of perspectives in epidemic management. All respondents believed to have contributed to policy or society, by influencing opinions, and occasionally by altering policy. However, respondents encountered obstacles in their attempts to contribute such as inability to establish contact with authorities, feeling unheard or undermined, and complications due to the interplay of political interests. In conclusion, CSEPs have fulfilled various roles such as providing alternative management policies, producing equipment, representing the needs of vulnerable populations, and supporting citizens and providing citizens with other viewpoints and information. The identified motivators to establish CSEPs in this study uncover room for improvements in policy. These insights, together with the identified perceived barriers of CSEPs, can be used to improve the connection between (future) epidemic management and public priorities and interests.

Identifiants

pubmed: 37607772
pii: bmjgh-2023-012875
doi: 10.1136/bmjgh-2023-012875
pmc: PMC10445389
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Public Health. 2021 Mar 19;66:591027
pubmed: 34744560
Glob Health Action. 2019;12(1):1662682
pubmed: 31507254
Prev Chronic Dis. 2020 Jul 16;17:E65
pubmed: 32678059
BMJ Glob Health. 2020 May;5(5):
pubmed: 32371570
Health Secur. 2015 Mar-Apr;13(2):69-73
pubmed: 25813979
Nature. 2019 Nov;575(7781):130-136
pubmed: 31695207
PLoS One. 2021 May 6;16(5):e0250614
pubmed: 33956831
Nat Hum Behav. 2020 May;4(5):439
pubmed: 32221513
Eur J Public Health. 2021 Nov 9;31(Supplement_4):iv50-iv53
pubmed: 34751361
Eur J Dev Res. 2022;34(1):432-454
pubmed: 33456209
Lancet Public Health. 2022 Jan;7(1):e86-e92
pubmed: 34906331
Rev Panam Salud Publica. 2023 Jun 12;47:e92
pubmed: 37324197
Environ Urban. 2020 Oct;32(2):503-522
pubmed: 36438604
Soc Sci Med. 2014 Dec;123:262-8
pubmed: 25147056
PLoS One. 2022 Mar 24;17(3):e0265404
pubmed: 35324975
J Flood Risk Manag. 2019 Sep;12(3):e12468
pubmed: 32051691
Lancet. 2021 Oct 30;398(10311):1567-1568
pubmed: 34755625
BMJ. 2021 May 26;373:n1207
pubmed: 34039589
Lancet. 2020 May 30;395(10238):1676-1678
pubmed: 32380042
N Engl J Med. 2014 Sep 25;371(13):1183-5
pubmed: 25140856
HRB Open Res. 2020 Jun 8;3:35
pubmed: 32666039
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33051285
BMC Public Health. 2010 Aug 19;10:501
pubmed: 20718996
Prog Disaster Sci. 2020 Oct;7:100102
pubmed: 34171013
Environ Dev Sustain. 2020;22(6):4953-4954
pubmed: 32837275
Aust J Prim Health. 2017 Dec;23(6):516-530
pubmed: 28641704

Auteurs

Sophie Kemper (S)

National Coordination Centre for Communicable Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands sophie.kemper@rivm.nl.
Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.

Renate van den Broek (R)

National Coordination Centre for Communicable Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.

Sarah van Hameren (S)

National Coordination Centre for Communicable Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.

J Frank H Kupper (JFH)

Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.

Marloes E J Bongers (MEJ)

National Coordination Centre for Communicable Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Esther de Weger (E)

Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.

Marion de Vries (M)

National Coordination Centre for Communicable Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Aura Timen (A)

Athena Institute, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands.
Primary and Community Care, Radboud University Medical Centre, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH